Costanzo MR, Mills RM, Wynne J.. Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). Am Heart J. 2008;155(2):339-347. doi: 10.1016/j.ahj.2007.10.020.
Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235. http://circ.ahajournals.org/content/112/12/e154.full.pdf+html. Accessed August 3, 2016.
The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, MA: Little, Brown & Co; 1994:253-256.
Jugdutt B, Butler C.Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support. J Am Coll Cardiol. 2007;49(11):1175-1177.
Kawashima D1, Gojo S, Nishimura T, et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 2011;57(3):169-176. doi: 10.1097/MAT.0b013e31820e121c.
Pieri M, Contri R, Winterton D, et al. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience. BMC Cardiovasc Disord. 2015;15:126. doi: 10.1186/s12872-015-0119-9.
Maini B, Gregory D, Scotti DJ, Buyantseva L. Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: Cost-Effectiveness in the Emergent Setting. Catheter Cardiovasc Interv. 2014;83(6):E183-E192. doi: 10.1002/ccd.25247.
Cheung A, Danter M, Gregory D. Comparative economic outcomes in cardiogenic shock patients managed with the minimally invasive Impella or extracorporeal life support [abstract]. J Am Coll Cardiol. 2012;60(17, Suppl B):B110. Abstract TCT-385. doi:10.1016/j.jacc.2012.08.413.
Gregory D, Scotti DJ, de Lissovoy G, et al. A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention. Am Health Drug Benefits. 2013;6(2):88-99.